Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Cohn

Showing results (41-50 of 183) with videos related to

Pageof 19
Sort By:
Targeted Oncology|September 13, 2012
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastomaAndres Morales La Madrid, Andres Morales La Madrid, Nicholas Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology GroupJennifer Schneiderman, Wendy B London, Garrett M Brodeur, et al.
Pediatric Blood & Cancer|September 25, 2014
Second malignancies in patients with neuroblastoma: the effects of risk-based therapyMark A Applebaum, Tara O Henderson, Sang Mee Lee, et al.
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses|January 8, 2017
The Role of Nursing Professionals in the Management of Patients With High-Risk Neuroblastoma Receiving Dinutuximab TherapyRita Secola, Araz Marachelian, Susan L Cohn, et al.
Cancer Research|October 20, 2004
Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARCAlexandre Chlenski, Shuqing Liu, Lisa J Baker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2009
Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumorsRana Zeine, Helen R Salwen, Radhika Peddinti, et al.
The Journal of Biological Chemistry|November 17, 2001
HuD, a neuronal-specific RNA-binding protein, increases the in vivo stability of MYCN RNAChitra F Manohar, Marc L Short, Anthony Nguyen, et al.
Cancer Research|February 20, 2007
Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastomaQiwei Yang, Yufeng Tian, Shuqing Liu, et al.
International Journal of Cancer|July 30, 2005
SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrixAlexandre Chlenski, Shuqing Liu, Lisa J Guerrero, et al.
The American Journal of Pathology|March 4, 2005
Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenograftsShuqing Liu, Yufeng Tian, Alexandre Chlenski, et al.
Pageof 19

Showing results (41-50 of 183) with videos related to

Sort By:
Pageof 19
Targeted Oncology|September 13, 2012
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastomaAndres Morales La Madrid, Andres Morales La Madrid, Nicholas Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology GroupJennifer Schneiderman, Wendy B London, Garrett M Brodeur, et al.
Pediatric Blood & Cancer|September 25, 2014
Second malignancies in patients with neuroblastoma: the effects of risk-based therapyMark A Applebaum, Tara O Henderson, Sang Mee Lee, et al.
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses|January 8, 2017
The Role of Nursing Professionals in the Management of Patients With High-Risk Neuroblastoma Receiving Dinutuximab TherapyRita Secola, Araz Marachelian, Susan L Cohn, et al.
Cancer Research|October 20, 2004
Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARCAlexandre Chlenski, Shuqing Liu, Lisa J Baker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2009
Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumorsRana Zeine, Helen R Salwen, Radhika Peddinti, et al.
The Journal of Biological Chemistry|November 17, 2001
HuD, a neuronal-specific RNA-binding protein, increases the in vivo stability of MYCN RNAChitra F Manohar, Marc L Short, Anthony Nguyen, et al.
Cancer Research|February 20, 2007
Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastomaQiwei Yang, Yufeng Tian, Shuqing Liu, et al.
International Journal of Cancer|July 30, 2005
SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrixAlexandre Chlenski, Shuqing Liu, Lisa J Guerrero, et al.
The American Journal of Pathology|March 4, 2005
Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenograftsShuqing Liu, Yufeng Tian, Alexandre Chlenski, et al.
Pageof 19